Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma

To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to compare 2 laser energy settings used for treatment. In a prospective clinical trial in Cape Coast and Accra, Ghana, 1 eye of each of 92 patient...

Full description

Saved in:
Bibliographic Details
Published inArchives of ophthalmology (1960) Vol. 119; no. 3; p. 345
Main Authors Egbert, P R, Fiadoyor, S, Budenz, D L, Dadzie, P, Byrd, S
Format Journal Article
LanguageEnglish
Published United States 01.03.2001
Subjects
Online AccessGet more information

Cover

Loading…
Abstract To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to compare 2 laser energy settings used for treatment. In a prospective clinical trial in Cape Coast and Accra, Ghana, 1 eye of each of 92 patients with primary open-angle glaucoma was treated by diode laser TSCPC as a primary surgical treatment. Eyes were randomly assigned to receive treatment by 20 applications of either 1.5 W applied for 1.5 seconds or 1.25 W applied for 2.5 seconds. Seventy-nine (86%) of 92 patients completed 3 months of follow-up; follow-up was 13.2 +/- 6.0 months (mean +/- SD). Intraocular pressure decreased in 53 (67%) of the 79 eyes. The drop in intraocular pressure was 20% or more in 37 eyes (47%) and final intraocular pressure was 22 mm Hg or less in 38 eyes (48%). An atonic pupil was a previously unreported complication that arose in 27 (28%) of 92 eyes. There were no serious complications of hypotony, phthisis bulbi, or sympathetic ophthalmia. Visual acuity decreased in 18 (23%) of 79 eyes treated by TSCPC and in 10 (23%) of 47 fellow eyes treated only with glaucoma medications. There was no difference in outcomes between the 2 laser energy settings. Diode laser TSCPC is a practical, rapid, well-tolerated procedure that may provide a modest and variable lowering of intraocular pressure. The treatment, used with conservative energy levels applied to the eye, seems to have few serious complications, although a previously unrecognized complication of atonic pupil needs further evaluation. A moderate variation in laser energy settings does not influence the results of treatment.
AbstractList To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to compare 2 laser energy settings used for treatment. In a prospective clinical trial in Cape Coast and Accra, Ghana, 1 eye of each of 92 patients with primary open-angle glaucoma was treated by diode laser TSCPC as a primary surgical treatment. Eyes were randomly assigned to receive treatment by 20 applications of either 1.5 W applied for 1.5 seconds or 1.25 W applied for 2.5 seconds. Seventy-nine (86%) of 92 patients completed 3 months of follow-up; follow-up was 13.2 +/- 6.0 months (mean +/- SD). Intraocular pressure decreased in 53 (67%) of the 79 eyes. The drop in intraocular pressure was 20% or more in 37 eyes (47%) and final intraocular pressure was 22 mm Hg or less in 38 eyes (48%). An atonic pupil was a previously unreported complication that arose in 27 (28%) of 92 eyes. There were no serious complications of hypotony, phthisis bulbi, or sympathetic ophthalmia. Visual acuity decreased in 18 (23%) of 79 eyes treated by TSCPC and in 10 (23%) of 47 fellow eyes treated only with glaucoma medications. There was no difference in outcomes between the 2 laser energy settings. Diode laser TSCPC is a practical, rapid, well-tolerated procedure that may provide a modest and variable lowering of intraocular pressure. The treatment, used with conservative energy levels applied to the eye, seems to have few serious complications, although a previously unrecognized complication of atonic pupil needs further evaluation. A moderate variation in laser energy settings does not influence the results of treatment.
Author Egbert, P R
Dadzie, P
Byrd, S
Budenz, D L
Fiadoyor, S
Author_xml – sequence: 1
  givenname: P R
  surname: Egbert
  fullname: Egbert, P R
  email: egbert@stanford.edu
  organization: Department of Ophthalmology, Stanford University Medical Center, Room A 157, Stanford, CA 94305-5308. egbert@stanford.edu
– sequence: 2
  givenname: S
  surname: Fiadoyor
  fullname: Fiadoyor, S
– sequence: 3
  givenname: D L
  surname: Budenz
  fullname: Budenz, D L
– sequence: 4
  givenname: P
  surname: Dadzie
  fullname: Dadzie, P
– sequence: 5
  givenname: S
  surname: Byrd
  fullname: Byrd, S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11231767$$D View this record in MEDLINE/PubMed
BookMark eNo9T0tLxDAYzGHFfegf8CD5A635kr5ylPUJC170vHxNk24lTUqSHvbfW3CVOQzDDMPMlqycd5qQO2A5MAYPGNTJT6eUA8hc5KIoV2TDGBOZlCVbk22M34usgMlrsgbgAuqq3hD3NPhOU4tRB5oCuhiV1QEtVWdll0afvPLYzxbT4B3FSJFOYRgxnGmcQz-oJZuCxjRql6jx4d_2k3YZut5q2luclR_xhlwZtFHfXnhHvl6eP_dv2eHj9X3_eMiwEE3KoJalYkXNi6JrWyEN590CLjlH0Aa6QiEzooRKs7YEXYpS6qYSBnhlmkbyHbn_7Z3mdtTd8TLp-Hec_wCj4F5d
CitedBy_id crossref_primary_10_2147_OPTH_S447875
crossref_primary_10_3928_23258160_20130503_06
crossref_primary_10_1007_s00417_016_3563_z
crossref_primary_10_1007_s00347_018_0677_1
crossref_primary_10_1111_cxo_13114
crossref_primary_10_1007_s00417_010_1363_4
crossref_primary_10_3390_vision1040024
crossref_primary_10_3109_08820538_2016_1154163
crossref_primary_10_1046_j_1442_9071_2003_00777_x
crossref_primary_10_1007_s10792_019_01093_w
crossref_primary_10_1007_s00347_017_0609_5
crossref_primary_10_1007_s10384_022_00938_9
crossref_primary_10_1016_j_preteyeres_2020_100879
crossref_primary_10_1078_1615_1615_00079
crossref_primary_10_1002_lsm_22202
crossref_primary_10_1097_00061198_200406000_00011
crossref_primary_10_1586_eop_09_66
crossref_primary_10_1097_IJG_0000000000001552
crossref_primary_10_1016_j_ophtha_2024_01_014
crossref_primary_10_1097_IJG_0000000000000503
crossref_primary_10_1007_s10103_019_02922_1
crossref_primary_10_1038_sj_eye_6702345
crossref_primary_10_1111_aos_15754
crossref_primary_10_1097_00055735_200404000_00011
crossref_primary_10_1097_IIO_0000000000000235
crossref_primary_10_1111_ceo_12558
crossref_primary_10_1097_IJG_0000000000000370
crossref_primary_10_3390_jcm9072039
crossref_primary_10_1007_s00417_015_3159_z
crossref_primary_10_1111_aos_14661
crossref_primary_10_1007_s00417_013_2441_1
crossref_primary_10_1016_j_ajoc_2024_102072
crossref_primary_10_1038_sj_eye_6700178
crossref_primary_10_1016_j_ophtha_2020_06_051
crossref_primary_10_1111_aos_12913
crossref_primary_10_21516_2072_0076_2024_17_1_136_143
crossref_primary_10_3928_1542_8877_20050701_04
crossref_primary_10_1016_j_jfo_2016_10_013
crossref_primary_10_1007_s12325_016_0330_9
crossref_primary_10_1007_s10792_018_0834_1
crossref_primary_10_1097_ICO_0b013e318156d1eb
crossref_primary_10_1097_IJG_0000000000001057
crossref_primary_10_1016_j_jcjo_2021_01_015
crossref_primary_10_1097_IJG_0000000000001339
crossref_primary_10_1038_eye_2012_269
crossref_primary_10_1097_ICU_0b013e32835d9335
crossref_primary_10_1136_bmjopen_2013_002793
crossref_primary_10_1097_IJG_0000000000001008
crossref_primary_10_1111_aos_14125
crossref_primary_10_5301_ejo_5000389
crossref_primary_10_3109_08820538_2013_874487
crossref_primary_10_1080_08820538_2023_2168489
crossref_primary_10_1007_s10792_021_01893_z
crossref_primary_10_1097_00061198_200208000_00009
crossref_primary_10_1007_s00417_006_0280_z
crossref_primary_10_15406_mojcr_2018_08_00244
crossref_primary_10_1016_j_ogla_2018_08_007
crossref_primary_10_1007_s00417_021_05436_1
crossref_primary_10_1002_14651858_CD009313_pub2
crossref_primary_10_1016_j_ogla_2020_04_004
crossref_primary_10_1111_j_1442_9071_2006_01368_x
crossref_primary_10_1016_j_jnma_2021_12_005
crossref_primary_10_1080_17469899_2022_2108790
crossref_primary_10_1046_j_1442_9071_2002_00553_x
crossref_primary_10_1097_01_ijg_0000151890_41239_c5
crossref_primary_10_1016_j_ajo_2021_04_003
crossref_primary_10_1016_j_jcjo_2016_07_013
crossref_primary_10_1097_IJG_0000000000002284
crossref_primary_10_1136_bjophthalmol_2021_319757
crossref_primary_10_1097_IJG_0000000000000666
crossref_primary_10_1080_09286586_2018_1501499
crossref_primary_10_1097_IJG_0000000000001997
crossref_primary_10_3341_jkos_2022_63_2_183
crossref_primary_10_1111_aos_16652
crossref_primary_10_1080_08820538_2022_2152702
crossref_primary_10_1089_10445470152612026
crossref_primary_10_1097_IJG_0b013e31815f2539
crossref_primary_10_1111_ceo_13328
crossref_primary_10_1016_j_jfo_2021_06_006
crossref_primary_10_1016_j_ophtha_2003_11_008
crossref_primary_10_4137_OED_S4909
crossref_primary_10_1046_j_1442_9071_2004_00754_x
crossref_primary_10_1007_s00417_021_05157_5
crossref_primary_10_1080_17469899_2021_1951232
crossref_primary_10_1097_00061198_200108000_00016
crossref_primary_10_1097_APO_0000000000000294
crossref_primary_10_1002_14651858_CD012223_pub2
crossref_primary_10_1097_IJG_0000000000001023
crossref_primary_10_1097_IJG_0000000000002079
crossref_primary_10_1177_11206721221149514
crossref_primary_10_1097_IJG_0000000000001426
crossref_primary_10_1097_IJG_0000000000002237
crossref_primary_10_1007_s00417_006_0421_4
crossref_primary_10_17816_OV11132
crossref_primary_10_1111_ceo_12088
crossref_primary_10_1016_j_sjopt_2009_12_002
crossref_primary_10_1097_00061198_200308000_00011
crossref_primary_10_3109_02656736_2014_984777
crossref_primary_10_1111_j_1600_0420_2006_00746_x
crossref_primary_10_1016_j_ogla_2019_02_002
crossref_primary_10_1080_08820538_2019_1638946
crossref_primary_10_1111_ceo_12360
crossref_primary_10_1007_s00417_007_0708_0
crossref_primary_10_1002_14651858_CD004399_pub3
crossref_primary_10_3341_jkos_2015_56_11_1759
crossref_primary_10_1016_j_survophthal_2019_01_001
crossref_primary_10_1097_IJG_0000000000002346
crossref_primary_10_1016_S0161_6420_02_01019_9
crossref_primary_10_4103_tjosr_tjosr_27_22
crossref_primary_10_1097_00061198_200206000_00007
crossref_primary_10_1007_s00417_021_05468_7
crossref_primary_10_1007_s00717_008_0267_8
crossref_primary_10_1007_s11701_013_0424_1
crossref_primary_10_1016_j_pdpdt_2021_102580
crossref_primary_10_1016_j_ogla_2020_12_014
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1001/archopht.119.3.345
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 11231767
Genre Comparative Study
Clinical Trial
Evaluation Studies
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-QF
.55
.XZ
23N
2CT
2WC
354
39C
3O-
4.4
53G
5GY
6J9
AAWTL
ABCQX
ABJNI
ABOCM
ACGFS
ADBBV
AFFNX
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ARBJA
BAWUL
BCGUY
BRYMA
C1A
C45
CGR
CS3
CUY
CVF
EAM
EBS
ECM
EIF
EJD
EMOBN
EX3
F5P
L7B
MJL
N4W
N9A
NPM
OB3
OBH
OGROG
OHH
OVD
P2P
RAJ
SJN
SV3
TEORI
WH7
WOW
X7M
XHN
YOC
ZGI
ZXP
ZY1
ID FETCH-LOGICAL-a438t-1795c047244dbb39f22d2d22922a1ef1d4ca0f3516e0b51e5359e863f126f8892
ISSN 0003-9950
IngestDate Sat Sep 28 08:38:47 EDT 2024
IsPeerReviewed false
IsScholarly false
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a438t-1795c047244dbb39f22d2d22922a1ef1d4ca0f3516e0b51e5359e863f126f8892
PMID 11231767
ParticipantIDs pubmed_primary_11231767
PublicationCentury 2000
PublicationDate 2001-03-01
PublicationDateYYYYMMDD 2001-03-01
PublicationDate_xml – month: 03
  year: 2001
  text: 2001-03-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Archives of ophthalmology (1960)
PublicationTitleAlternate Arch Ophthalmol
PublicationYear 2001
References 11231776 - Arch Ophthalmol. 2001 Mar;119(3):424-5
References_xml
SSID ssj0006109
Score 1.7231371
Snippet To evaluate the feasibility of diode laser transscleral cyclophotocoagulation (TSCPC) as a primary surgical treatment for primary open-angle glaucoma and to...
SourceID pubmed
SourceType Index Database
StartPage 345
SubjectTerms Adult
Aged
Aged, 80 and over
Ciliary Body - surgery
Feasibility Studies
Female
Glaucoma, Open-Angle - surgery
Humans
Intraocular Pressure
Laser Coagulation
Male
Middle Aged
Postoperative Complications
Prospective Studies
Reoperation
Sclera
Treatment Outcome
Visual Acuity
Title Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma
URI https://www.ncbi.nlm.nih.gov/pubmed/11231767
Volume 119
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF6qgngR32_Zg7eSYrJJmj2qbRGhxYOCN9lNdmuhJqVND-3f8A87k2zSWB-oFELJpOkm82UyM8x8Q8iFVjySyg4sDb5olq2yAo4VAEKKJgQktmLY79zt-beP7t2T91SrvVWqlqapbITzL_tK_qNV2Ad6xS7ZP2i2PCnsgO-gX9iChmH7Kx23Bkmk6uD_qjHOeognEzgAO-7DWThMRi9JmoSJ6JsJXThSRtRHhl5iMh3nRm9Rao4Vh4UYp2pZIu4PVR0c7CmsXlT92CphLfxR-iKGrzmbExI_QbxSyTC0-9I0Bt0vyhM7AxEls-Tj1K9r5NnMMtqtepmUboloPqi0ohUpikqNVml2mcV5zjBbml1jKgfVsDwzoiwnmPxk3POhAvj844WBsecN1lg6GBQ0es3UDY4k-Eb5rI-fpUuE24Vohaw0AzSdPUwAmZc7stMXQxjxikwfFhJZfV4YMtKaky1FLZn38rBFNk3YQa9yDG2Tmop3yHrXFFbskjiDEs2gRKtQol9CiYoJFdRghRZQoiWUKECpFC-gRAso7ZHHTvvh5tYyozgs4bIgRRJbL0RiUdeNpGRcO04EH4c7jrCVtiM3FJeaebavLqVnK495XAU-07bj6yDgzj5ZjZNYHRJqN7GsQIfgqkuXuY7gSnAfrQT8KgijI3KQ36lns8zn4h4efys5IRsL3J2SNQ0PuDoDbzGV55n-3gF5nWoy
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diode+laser+transscleral+cyclophotocoagulation+as+a+primary+surgical+treatment+for+primary+open-angle+glaucoma&rft.jtitle=Archives+of+ophthalmology+%281960%29&rft.au=Egbert%2C+P+R&rft.au=Fiadoyor%2C+S&rft.au=Budenz%2C+D+L&rft.au=Dadzie%2C+P&rft.date=2001-03-01&rft.issn=0003-9950&rft.volume=119&rft.issue=3&rft.spage=345&rft_id=info:doi/10.1001%2Farchopht.119.3.345&rft_id=info%3Apmid%2F11231767&rft_id=info%3Apmid%2F11231767&rft.externalDocID=11231767
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9950&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9950&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9950&client=summon